Conversely, experimental findings suggest that MIR4435-2HG can enhance the proliferation and migration abilities of non-small cell lung cancer, ovarian cancer, and prostate cancer cells by increasing the expression of TGF-β and activating its signaling pathway [8,50,55]. This evidence concerns the gene TGFB1 and ovarian carcinoma.